VENUSREM.NS
Price:
$479.5
Market Cap:
$6.41B
Venus Remedies Limited develops and markets pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, anticoagulant, cardiac, disinfectant and antiseptic, gastro therapy, hand sanitizers, hormones, iron supplements, neurology, oncology, pain management, respiratory, skin and wound care, stress reliever, urology, and vitamins/minerals/nutrients, as well as antimicrobial resistance products. It also provides disinfectants; and a portfolio of herbal products. Venus Remedies Limited was incorporated in 1989 and is headquartered in Panchkula, India.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2006-12-20
Stock Exchange
NSE
Ticker
VENUSREM.NS
According to Venus Remedies Limited’s latest financial reports and current stock price. The company's current ROE is 8.90%. This represents a change of 310.69% compared to the average of 2.17% of the last 4 quarters.
The mean historical ROE of Venus Remedies Limited over the last ten years is 2.63%. The current 8.90% ROE has changed 237.89% with respect to the historical average. Over the past ten years (40 quarters), VENUSREM.NS's ROE was at its highest in in the March 2021 quarter at 8.77%. The ROE was at its lowest in in the March 2019 quarter at -3.45%.
Average
2.63%
Median
3.76%
Minimum
-8.59%
Maximum
15.43%
Discovering the peaks and valleys of Venus Remedies Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 351.16%
Maximum Annual ROE = 15.43%
Minimum Annual Increase = -599.01%
Minimum Annual ROE = -8.59%
Year | ROE | Change |
---|---|---|
2025 | 8.08% | 38.25% |
2024 | 5.84% | 1.24% |
2023 | 5.77% | -37.58% |
2022 | 9.25% | -40.08% |
2021 | 15.43% | -599.01% |
2020 | -3.09% | -64.02% |
2019 | -8.59% | 1.33% |
2018 | -8.48% | -584.23% |
2017 | 1.75% | 351.16% |
2016 | 0.39% | -65.65% |
The current ROE of Venus Remedies Limited (VENUSREM.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.56%
5-year avg
8.87%
10-year avg
2.63%
Venus Remedies Limited’s ROE is less than Vimta Labs Limited (20.31%), less than RPG Life Sciences Limited (44.04%), less than Themis Medicare Limited (7.44%), greater than Indoco Remedies Limited (-6.84%), less than SMS Pharmaceuticals Limited (12.01%),
Company | ROE | Market cap |
---|---|---|
20.31% | $20.43B | |
44.04% | $41.99B | |
7.44% | $11.52B | |
-6.84% | $30.38B | |
12.01% | $21.07B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Venus Remedies Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Venus Remedies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Venus Remedies Limited's ROE?
How is the ROE calculated for Venus Remedies Limited (VENUSREM.NS)?
What is the highest ROE for Venus Remedies Limited (VENUSREM.NS)?
What is the 3-year average ROE for Venus Remedies Limited (VENUSREM.NS)?
What is the 5-year average ROE for Venus Remedies Limited (VENUSREM.NS)?
How does the current ROE for Venus Remedies Limited (VENUSREM.NS) compare to its historical average?